LOCALLY ADVANCED HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA

Clinical trials for LOCALLY ADVANCED HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug joins fight against tough head and neck cancers

Disease control Recruiting now

This early-stage study is testing whether adding a new oral drug called ipatasertib to the standard treatment of chemotherapy plus radiation is safe and more effective for people with locally advanced head and neck cancer. The main goal is to find the safest and most effective do…

Matched conditions: LOCALLY ADVANCED HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

LOCALLY ADVANCED HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA

Get alerted when new LOCALLY ADVANCED HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear

New drug joins fight against tough head and neck cancers